The partnership between the Federal University of Rio de Janeiro and Fiocruz to install in the Science Park a Center of National Reference in Pharmochemistry of the Farmanguinhos/Fiocruz Drugs Institute made the headlines of GloboNews. The partnership will enable the development, in a pilot scale, of Active Pharmaceutical Ingredients (IFAs – Insumos Farmacêuticos Ativos). Farmanguinhos is the largest laboratory of the official network of the Ministry of Health and one of the major suppliers for Brazil’s Unified Public Health System (Sistema Único de Saúde – SUS). The Park’s CEO, José Carlos Pinto, gave an interview to GloboNews talking about the benefits that will arise after the opening of this new center. Check the whole report at GloboNews website.